{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-046176","form_type":"8-K","ticker":"KYTX","cik":"0001994702","company_name":"Kyverna Therapeutics, Inc.","filed_at":"2025-03-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.731743+00:00","generated_at":"2026-05-24T04:24:09.382315+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Kyverna Therapeutics enters into $50M at-the-market equity offering facility with Jefferies","bullets":["Agreement with Jefferies LLC allows sale of up to $50M of common stock from time to time.","Agent compensation set at 3.0% of gross sales price per share sold.","Company has no obligation to sell any shares under the Sales Agreement.","Sales will be made under Company's existing shelf registration statement (Form S-3) filed same day."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-046176","json":"https://secwatch.observer/filing/0000950170-25-046176.json","markdown":"https://secwatch.observer/filing/0000950170-25-046176.md","text":"https://secwatch.observer/filing/0000950170-25-046176.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1994702/000095017025046176/0000950170-25-046176-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1994702/000095017025046176/kytx-20250327.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T04:24:09.382315+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}